Key Highlights
- Elementis plc (LSE:ELM) shares rose 2.76% on Wednesday, 30 September 2026.
- H1 2026 adjusted operating profit increased 16.4% to $73.2 million, with the Margin reaching 23.0%.
- Revenue grew 4.7% organically at constant currency to $318.2 million.
- A share buyback of around £25 million, funded by the sale of its pharmaceutical Manufacturing business, is ongoing.
- Company-compiled consensus points to 2026 adjusted operating profit of $132.5 million.
Shares Move Higher
Elementis plc (LSE:ELM), the pure-play specialty chemicals group, gained 2.76% on 30 September 2026, building on steady buyback support. The company repurchased more than 330,000 shares between 21 and 25 September at prices around 176p to 178p, and continues to buy in the market.
The broad rally in UK mid-cap stocks, helped by lower gilt yields, also supported the move.
H1 2026: Strong Profit and Margin Growth
For the six months to 30 June 2026, Elementis reported Revenue of $318.2 million, up 9.4% on a reported basis and 4.7% organically at constant currency. Adjusted operating profit rose 16.4% to $73.2 million, and the adjusted Operating Margin improved by 140 basis points to 23.0%. Adjusted diluted EPS increased 28.8% to 8.5 cents.
Coatings revenue rose 5.6% organically to $209.0 million, with adjusted operating profit up 18.7% and margin climbing to 20.7%. Personal Care revenue grew 2.9% to $109.2 million, with a margin of 38.1%, aided by the sale of the pharmaceutical manufacturing business.
Elevate Elementis Strategy
One year into its Elevate Elementis strategy, the group has delivered on key targets. It has sold its Talc, chromium and pharmaceutical manufacturing businesses, becoming a focused specialty additives company. Medium-term targets include mid-single-digit revenue growth, an adjusted operating margin of 23% or more, operating cash conversion above 90% and return on Capital employed above 30%.
The group has achieved the 23% margin target in the first half, though management cautioned that the margin will moderate in the second half because of normal seasonal weighting. Self-help savings since the strategy launch reached $7.3 million, with a $10 million net savings target expected by the end of 2026 or early 2027.
Balance Sheet and Buyback
Net Debt fell to $163.8 million from $185.4 million at the end of 2025, close to the company's 1 times Leverage target. The share buyback, announced in June 2026 and funded by disposal proceeds, reduces share count and supports earnings per share. In 2025, Elementis also completed a £40 million buyback.
Analyst Support
Analysts are broadly positive. Berenberg has a buy rating with a 220p target, Deutsche Bank has a buy rating with a 215p target, and Kepler Cheuvreux initiated coverage with a buy rating. JPMorgan holds a neutral stance with a 190p target.
Board Update
In September, Elementis appointed a new senior independent director, strengthening its board as the strategy progresses.
Why Investors Are Watching LSE:ELM
- Margin sustainability: holding margins near 23% through the cycle would support a re-rating.
- Coatings demand: industrial and decorative coatings markets remain cyclical.
- Hectorite and skincare growth: high-value products drive profitability.
- Buyback execution: ongoing purchases support the share price.
- Full-year delivery: consensus adjusted operating profit is $132.5 million.
Risks to Consider
Macroeconomic uncertainty, Middle East tensions affecting energy costs, weaker coatings Demand and currency movements could affect results.
Outlook
The 2.76% gain in LSE:ELM reflects growing confidence in the Elevate Elementis strategy. With strong margins, lower debt, a solid order book for the third quarter and continued buybacks, Elementis is positioning itself as a higher-quality specialty chemicals business.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...